search
SLS009
Trends
- 1Sellas Shares Climb Overnight Despite Citi's 64% Stake Cut▼SLS Stock Rises Overnight Despite Citi’s 64% Stake Cut — Retail Bulls Say SLS009 Alone Could Outvalue Sellas
Shares of Sellas Life Sciences rose in overnight trading even after Citigroup reported a 64% reduction in its stake in the company. Retail investors pushed back against the bearish signal, arguing that the drug candidate SLS009 alone could be worth more than Sellas' entire current market value, framing the stock as undervalued ahead of the drug's development milestones.